跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
潘 俊旭
專案助理教授
,
新藥研發產業博士學位學程
合聘專案助理教授
,
藥物科學學科
https://orcid.org/0000-0001-8700-583X
電子郵件
panch
tmu.edu
tw
h-index
952
引文
18
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
2005
2025
每年研究成果
概覽
指紋
網路
專案
(1)
研究成果
(51)
類似的個人檔案
(6)
指紋
查看啟用 Chun-Hsu Pan 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Neointima
85%
Tumor Model
80%
Hyperplasia
80%
Restenosis
69%
Lung Cancer
68%
Non Small Cell Lung Cancer
62%
Gelatinase A
50%
Inflammation
47%
Malignant Neoplasm
45%
Protein Kinases
45%
Lung Adenocarcinoma
44%
Adenosine Phosphate
43%
Acetyl-CoA
43%
Carboxylase
43%
Gelatinase B
41%
Atherogenesis
40%
Injury
39%
Hyperlipidemia
38%
Tumor Growth
37%
Vasculotropin
35%
Ethanol
35%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
35%
Fucus vesiculosus
35%
Ascophyllum
35%
Matrix Metalloproteinase
35%
Mouse
35%
Angiotensin II
34%
Neoplasm
34%
Antilipemic Agent
32%
Lactobacillus casei
32%
Rabbit Model
29%
angiotensin[1-7]
29%
Nanoparticle
26%
Mitogen Activated Protein Kinase 3
25%
Probiotic Agent
25%
Antioxidant
25%
Intestine Flora
23%
Bagg Albino Mouse
23%
Yam
23%
Metabolic Syndrome X
23%
Inducible Nitric Oxide Synthase
22%
Gelatinase
21%
Disease
20%
Hypolipemia
19%
Traditional Chinese Medicine
19%
Angiotensin
19%
Drug Resistance
19%
Cell Viability
19%
Chemokine Receptor CXCR4
17%
Senescence Accelerated Mouse
17%
Medicine and Dentistry
Vascular Smooth Muscle Cell
100%
Percutaneous Transluminal Angioplasty
94%
Neointimal Hyperplasia
78%
Supplementation
70%
Neointima
61%
Cell Migration
55%
Cell Proliferation
54%
Restenosis
53%
Gut Microbiota
51%
In Vitro
43%
down Regulation
40%
Gelatinase A
36%
Atrial Fibrillation
35%
Parkinson's Disease
35%
Cell Growth
35%
Probiotic Agent
32%
Macrophage
31%
Signal Transduction
26%
Tumor Progression
23%
Tumor Model
23%
Vasculotropin
23%
Allograft
23%
Antioxidant
23%
Gut Microbiome
23%
Inducible Nitric Oxide Synthase
22%
Angiogenesis
20%
Antiangiogenic Activity
20%
Lung Cancer
20%
Hyperplasia
19%
Salvianolic Acid B
17%
Stromal Cell Derived Factor 1
17%
Chemokine Receptor CXCR4
17%
Sleep Deprivation
17%
Antiinflammatory Activity
17%
Human Umbilical Vein Endothelial Cell
17%
Chinese Herbal Medicine
17%
Angiotensin Converting Enzyme 2
17%
Carrageenan-Induced Paw Edema
17%
Cardiovascular System
17%
Lactobacillus Casei Shirota
17%
Jejunum Ulcer
17%
microRNA
17%
Leukemia Cell
17%
Sarcopenia
17%
Vascular Endothelial Cell
17%
Tongue
17%
Vasculotropin Receptor 2
17%
Saponin
17%
IC50
17%
Nanocarrier
17%
Biochemistry, Genetics and Molecular Biology
Cell Growth
89%
down Regulation
59%
Cell Migration
52%
Cancer Cell
44%
Angiotensin-Converting Enzyme
35%
Atrial Fibrillation
35%
Tumor Progression
24%
Oxidative Stress
23%
Angiotensin
23%
MMP9
22%
Gelatinase B
22%
Gene Expression
21%
Intestine Flora
20%
Signal Transduction
20%
Platelet Derived Growth Factor Receptor Beta
19%
Oxidative Coupling
17%
FHL1
17%
Antrodia camphorata
17%
Protein Repeat
17%
Ankyrin Repeat
17%
Senescence Accelerated Mouse
17%
Mouse
17%
Antiangiogenic Activity
17%
Ankyrin
17%
Kinase Insert Domain Receptor
17%
Vascular Endothelial Growth Factor
17%
Phosphoglycerate Kinase
17%
Starch Synthase
17%
Vigna
17%
Drug Resistance
17%
Transforming Growth Factor
17%
Transcription Factors
17%
MicroRNA
17%
Protein Expression
17%
Extract
15%
P53
15%
Lactobacillus casei
14%
Gelatinase
13%
Cell Proliferation
13%
Caspase 3
13%
Platelet-Derived Growth Factor Receptor
12%
P21
12%
Enzyme
11%
Promoter Region
10%
Cell Cycle M Phase
10%
Cell Cycle
10%
Cell Viability
10%
Enzyme Activity
9%
MMP2
9%
Gelatinase A
9%